Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Z Leder

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Response to Letter to the Editor From Riahi and Gruntmanis: "Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates"WuQiang Fan, Benjamin Z Leder, Marcy B Bolster
The Journal of Clinical Endocrinology and Metabolism|September 8, 2011
Bisphosphonates for osteoporosis: benefits and risksJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|April 9, 2013
Medicines and bone lossJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|June 4, 2013
HypoparathyroidismJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|February 8, 2012
Glucocorticoid-induced osteoporosisJens Bollerslev, Steven T Harris, Benjamin Z Leder
Bone|December 13, 2006
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in menSherri-Ann M Burnett-Bowie, Natalia Mendoza, Benjamin Z Leder
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 7, 2024
One versus 2 years of alendronate following denosumab: the CARD extensionJoy N Tsai, Mackenzie Jordan, Hang Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2024
Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functionsXiaoxu Sun, Marcy B Bolster, Benjamin Z Leder, et al.
Bone|March 14, 2017
Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)Benjamin Z Leder, Joy N Tsai, Linda A Jiang, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumab - Authors' replyBenjamin Z Leder, Sabashini K Ramchand, Hang Lee, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Response to Letter to the Editor From Riahi and Gruntmanis: "Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates"WuQiang Fan, Benjamin Z Leder, Marcy B Bolster
The Journal of Clinical Endocrinology and Metabolism|September 8, 2011
Bisphosphonates for osteoporosis: benefits and risksJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|April 9, 2013
Medicines and bone lossJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|June 4, 2013
HypoparathyroidismJens Bollerslev, Steven T Harris, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|February 8, 2012
Glucocorticoid-induced osteoporosisJens Bollerslev, Steven T Harris, Benjamin Z Leder
Bone|December 13, 2006
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in menSherri-Ann M Burnett-Bowie, Natalia Mendoza, Benjamin Z Leder
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 7, 2024
One versus 2 years of alendronate following denosumab: the CARD extensionJoy N Tsai, Mackenzie Jordan, Hang Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2024
Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functionsXiaoxu Sun, Marcy B Bolster, Benjamin Z Leder, et al.
Bone|March 14, 2017
Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)Benjamin Z Leder, Joy N Tsai, Linda A Jiang, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumab - Authors' replyBenjamin Z Leder, Sabashini K Ramchand, Hang Lee, et al.
Pageof 9